Table 1.
Demographic and clinical characteristics of patients with COVID-19.
| Total |
Sex |
Age (yr) |
|||||
|---|---|---|---|---|---|---|---|
| (n=1792) | Male (n=924) | Female (n=868) | <40 (n=208) | 40–59 (n=568) | 60–79 (n=866) | ≥80 (n=150) | |
| Spectrum of disease | |||||||
| Moderate | 109 (6.1) | 59 (6.4) | 50 (5.8) | 14 (6.7) | 38 (6.7) | 48 (5.5) | 9 (6.0) |
| Severe | 1,432 (79.9) | 712 (77.1) | 720 (82.9) | 181 (87.0) | 470 (82.7) | 674 (77.8) | 107 (71.3) |
| Critical | 251 (14.0) | 153 (16.6) | 98 (11.3) | 13 (6.3) | 60 (10.6) | 144 (16.6) | 34 (22.7) |
| Respiratory support during hospitalisation∗ | |||||||
| No | 247 (13.8) | 126 (13.6) | 121 (13.9) | 56 (26.9) | 98 (17.3) | 90 (10.4) | 3 (2.0) |
| LFNC | 1,133 (63.2) | 553 (59.8) | 580 (66.8) | 133 (63.9) | 373 (65.7) | 539 (62.2) | 88 (58.7) |
| LFM | 77 (4.3) | 41 (4.4) | 36 (4.1) | 5 (2.4) | 20 (3.5) | 39 (4.5) | 13 (8.7) |
| HFNC | 60 (3.3) | 41 (4.4) | 19 (2.2) | 3 (1.4) | 15 (2.6) | 33 (3.8) | 9 (6.0) |
| NIPPV | 135 (7.5) | 84 (9.1) | 51 (5.9) | 1 (0.5) | 29 (5.1) | 86 (9.9) | 19 (12.7) |
| IPPV | 104 (5.8) | 57 (6.2) | 47 (5.4) | 4 (1.9) | 22 (3.9) | 63 (7.3) | 15 (10.0) |
| ECMO | 10 (0.6) | 8 (0.9) | 2 (0.2) | 0 (0) | 6 (1.1) | 4 (0.5) | 0 (0) |
| Outcomes | |||||||
| Discharged | 1542 (86.0) | 760 (82.3) | 782 (90.1) | 201 (96.6) | 520 (91.5) | 716 (82.7) | 105 (70.0) |
| Died | 228 (12.7) | 150 (16.2) | 78 (9.0) | 5 (2.4) | 42 (7.4) | 138 (15.9) | 42 (28.0) |
| Transferred | 22 (1.2) | 14 (1.5) | 8 (0.9) | 2 (1.0) | 5 (0.9) | 12 (1.4) | 3 (2.0) |
| Length of stay (days)† | |||||||
| Discharged | 28 (20–41) | 28 (20–42) | 28 (20–40) | 22 (14–31.3) | 28 (21–41) | 29.5 (21–42) | 34 (24–43.8) |
| Died | 11 (6–20) | 10 (5–19) | 13 (6.5–22) | 10 (4.5–19) | 11.5 (5–20.8) | 12 (6–21) | 10 (5–16.5) |
| Transferred | 32.5 (20.8–46.3) | 31 (20.5–38) | 37 (19.5–62) | 24 (17–31) | 27 (17.5–35.5) | 37 (25–61.3) | 17 (4–56) |
| Respiratory support at discharge‡ | |||||||
| No | 1006 (65.2) | 495 (65.1) | 511 (65.3) | 173 (86.1) | 344 (66.2) | 434 (60.6) | 55 (52.4) |
| LFNC or LFM | 514 (33.3) | 256 (33.7) | 258 (33.0) | 28 (13.9) | 168 (32.3) | 270 (37.7) | 48 (45.7) |
Data are presented as median (interquartile range) or n (%).
ECMO, extracorporeal membrane oxygenation; HFNC, high-flow nasal cannula oxygen therapy; IPPV, invasive positive pressure ventilation; LFM, low-flow mask oxygen therapy; LFNC, low-flow nasal cannula oxygen therapy; NIPPV, noninvasive positive pressure ventilation.
∗
Only the highest level of respiratory support during hospitalisation is presented.
†
Transfers from one hospital to another were merged.
‡
Only patients who were discharged were included.